Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 515

Showing 1-25 of 515 citing articles:

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang, Fabian Schmidt, Yiska Weisblum, et al.
Nature (2021) Vol. 592, Iss. 7855, pp. 616-622
Open Access | Times Cited: 1438
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
BMJ (2021), pp. n1088-n1088
Open Access | Times Cited: 1202
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Erik Volz, Swapnil Mishra, Meera Chand, et al.
Nature (2021) Vol. 593, Iss. 7858, pp. 266-269
Open Access | Times Cited: 1189
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
Nicholas G. Davies, Christopher I Jarvis, W. John Edmunds, et al.
Nature (2021) Vol. 593, Iss. 7858, pp. 270-274
Open Access | Times Cited: 989
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian A. Lempp, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2332-2347.e16
Open Access | Times Cited: 936
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Robert Challen, Ellen Brooks‐Pollock, Jonathan M. Read, et al.
BMJ (2021), pp. n579-n579
Open Access | Times Cited: 831
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data
Erik Volz, Swapnil Mishra, Meera Chand, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 649
Genetic Variants of SARS-CoV-2—What Do They Mean?
Adam S. Lauring, Emma B. Hodcroft
JAMA (2021) Vol. 325, Iss. 6, pp. 529-529
Open Access | Times Cited: 624
Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study
Sam Moore, Edward M. Hill, Michael J. Tildesley, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 6, pp. 793-802
Open Access | Times Cited: 563
A guideline to limit indoor airborne transmission of COVID-19
Martin Z. Bazant, John W. M. Bush
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 17
Open Access | Times Cited: 421
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
Laura Vangeel, Winston Chiu, Steven De Jonghe, et al.
Antiviral Research (2022) Vol. 198, pp. 105252-105252
Open Access | Times Cited: 384
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen, Haili Tang, Charlene McDanal, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 529-539.e3
Open Access | Times Cited: 377
Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
Nicole L. Washington, Karthik Gangavarapu, Mark Zeller, et al.
Cell (2021) Vol. 184, Iss. 10, pp. 2587-2594.e7
Open Access | Times Cited: 356
Higher infectivity of the SARS‐CoV‐2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data
Abbas Khan, Tauqir Zia, Muhammad Suleman, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 10, pp. 7045-7057
Open Access | Times Cited: 338
Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Emma B. Hodcroft, Moira Zuber, Sarah Nadeau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 329
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
Carmen Gómez, Beatriz Perdiguero, Mariano Estéban
Vaccines (2021) Vol. 9, Iss. 3, pp. 243-243
Open Access | Times Cited: 267
The epidemiological impact of the NHS COVID-19 app
Chris Wymant, Luca Ferretti, Daphne Tsallis, et al.
Nature (2021) Vol. 594, Iss. 7863, pp. 408-412
Open Access | Times Cited: 260
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
Darren P. Martin, Steven Weaver, Houriiyah Tegally, et al.
Cell (2021) Vol. 184, Iss. 20, pp. 5189-5200.e7
Open Access | Times Cited: 252
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
Chadi M. Saad-Roy, Sinead E. Morris, C. Jessica E. Metcalf, et al.
Science (2021) Vol. 372, Iss. 6540, pp. 363-370
Open Access | Times Cited: 232
Emerging SARS-CoV-2 variants of concern and potential intervention approaches
Jasmin Khateeb, Yuchong Li, Haibo Zhang
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 228
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2
Chantal B. F. Vogels, Mallery I. Breban, Isabel M. Ott, et al.
PLoS Biology (2021) Vol. 19, Iss. 5, pp. e3001236-e3001236
Open Access | Times Cited: 221
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Floriane Gallais, Pierre Gantner, Timothée Bruel, et al.
EBioMedicine (2021) Vol. 71, pp. 103561-103561
Open Access | Times Cited: 212
Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant
Gard Nelson, Oleksandr Buzko, Patricia Spilman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 210
Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 199
Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 195
Page 1 - Next Page

Scroll to top